Stocks Drop As Israel-Iran Conflict Worsens… And A Shadow Over Solar Stocks 6/17/25
CNBC's "Fast Money"
00:00
Legislative Developments and Strategic Acquisitions in Biotech
This chapter examines the implications of the Genius Act and the Stable Act on digital asset regulation, alongside Eli Lilly's acquisition of Verve Therapeutics and its focus on gene editing innovations. It also discusses the competitive biotech landscape and Eli Lilly's strategy for pipeline diversification amidst market changes.
Transcript
Play full episode
